[1]
A. Mishra, S. Shrestha, S. K.C., and D. Karn, “A Prospective Clinical Study for Safety and Efficacy of Intralesional Tuberculin Purified Protein Derivative in Treatment of Palmoplantar Verruca”, J Nobel Med Coll, vol. 11, no. 1, pp. 12–16, Jun. 2022.